Aytu Biopharma Inc (AYTU)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2400 -0.0100 (-0.80%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2400 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | AYTU | APTO | BTAI | ||
| Company | Aytu Biopharma Inc | Aptose Bioscns | Bioxcel Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.3500 | 3.89 | 2.33 | ||
| High | 1.3500 | 3.95 | 2.50 | ||
| Low | 1.2200 | 3.37 | 2.30 | ||
| Last | 1.2400 | 3.69 | 2.33 | ||
| Change | -0.0100 | -0.24 | -0.03 | ||
| % Change | -0.80% | -6.11% | -1.27% | ||
| Volume | 30,900 | 43,500 | 479,000 | ||
| 20-Day Average Volume | 43,440 | 55,185 | 13,750,205 | ||
| Previous Close | 1.2500 | 3.93 | 2.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2501 | 3.45 | 2.43 | ||
| 20-Day Raw Stochastic | 39.13% | 53.21% | 11.94% | ||
| 20-Day Relative Strength | 40.20% | 43.43% | 42.19% | ||
| Weighted Alpha | -62.29 | -86.66 | -91.26 | ||
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.91% since 03/14/25 | unch since 03/14/25 | +9.39% since 03/14/25 | ||
| Low | 1.1500 on 03/19/25 | 3.37 on 03/21/25 | 2.04 on 03/18/25 | ||
| High | 1.3500 on 03/21/25 | 3.98 on 03/18/25 | 3.11 on 03/19/25 | ||
| 1-Month | |||||
| %Chg | -8.15% since 02/21/25 | -24.12% since 02/21/25 | +9.39% since 02/21/25 | ||
| Low | 1.1500 on 03/19/25 | 2.39 on 03/04/25 | 1.72 on 02/27/25 | ||
| High | 1.3800 on 02/25/25 | 4.83 on 02/24/25 | 6.83 on 03/03/25 | ||
| 3-Month | |||||
| %Chg | -10.14% since 12/20/24 | -55.91% since 12/20/24 | -57.29% since 12/20/24 | ||
| Low | 1.1500 on 03/19/25 | 2.39 on 03/04/25 | 1.72 on 02/27/25 | ||
| High | 1.9300 on 01/17/25 | 8.09 on 12/26/24 | 9.26 on 01/06/25 | ||
| 6-Month | |||||
| %Chg | -49.39% since 09/20/24 | -69.17% since 09/20/24 | -74.74% since 09/20/24 | ||
| Low | 1.1500 on 03/19/25 | 2.39 on 03/04/25 | 1.72 on 02/27/25 | ||
| High | 2.8500 on 09/26/24 | 12.60 on 09/27/24 | 13.28 on 10/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,651 | 7,901 | 7,469 | ||
| Shares Outstanding, K | 6,170 | 2,141 | 3,206 | ||
| Annual Sales | 81,000,000 | 0 | 1,380,000 | ||
| Annual Net Income | -15,840,000 | -51,210,000 | -179,050,000 | ||
| Last Quarter Sales | 16,220,000 | 0 | 210,000 | ||
| Last Quarter Net Income | 790,000 | -6,950,000 | -13,650,000 | ||
| 60-Month Beta | -1.63 | 1.14 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 02/12/25 | -11.11 on 11/08/24 | -5.12 on 11/14/24 | ||
| Latest Earnings Date | 02/12/25 | 03/25/25 | 03/25/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||